Introduction; Summary of economic models assessing pneumococcal vaccines in US

adults; EtR on risk-based use of PCV15 and PCV20 in adults; Considerations for use of PCV15 and PCV20 in adults and next steps

This video can also be viewed at

https://www.cdc.gov/vaccines/videos/low-res/ACIPSept2021/ACIP-3_PneumococcalVaccines_09-29-2021_LowRes.mp4

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.